Balance Labs Incorporates Subsidiary Balance AgroTech Co.

Balance AgroTech Intends to License or Acquire Developed and Proven Agricultural Technology Products and Solutions

MIAMI BEACH, FL -- (Marketwired) -- 03/03/16 -- Balance Labs, Inc. (OTCBB: BLNC), a provider of business development, consulting services as well as an incubator and accelerator to start ups and development stage companies, is pleased to announce the formation of a wholly owned subsidiary, Balance AgroTech Co.

Balance AgroTech intends to license and/or acquire agricultural technologies that are developed and proven and need some help entering their respective marketplaces. Balance Labs' associates and relationships throughout the growing, manufacturing and distribution process with substantial links throughout the food chain can be very helpful to small research and development focused agricultural technology companies. Balance AgroTech should be able to aggregate the various technologies it intends to acquire and or license and offer the technology to future clients.

The agricultural businesses of today, as well as those of the future, must cope with the feeding of 9.6 billion people that are currently estimated to call earth home in 2050. In order for that to occur food production must increase by 70%. This seems impossible with the limited and steadily shrinking availability of arable lands and let's not forget about the vast quantities of fresh water that will be needed. Advanced agricultural technology will be the only way to make this happen.

Balance Labs plans on distributing a portion of its holdings in Balance AgroTech Co. to its shareholders on a prorated basis. We will keep you updated as things progress.

Balance Labs' risk factors, corporate history and audited financials are available to the public along with other SEC filings at

For additional information, please visit

About Balance Labs Balance Labs is a business consulting firm and an incubator and accelerator of companies. We assist entrepreneurs in turning their dreams into reality. Balance Labs receives fees in royalties, equity and cash for the services it provides. Balance Labs plans on consistently distributing a portion of the equity it receives as fees or as a founding partner to its shareholders. For more information, please visit

This information does not constitute an offer to sell or a solicitation of an offer to buy securities or assets of Balance Labs. All information presented herein with respect to the existing business and the historical operating results of Balance Labs and estimates and projections as to future operations are based on materials prepared by the management of Balance Labs and involve significant elements of subjective judgment and analysis which may or may not be correct. While the information provided herein is believed to be accurate and reliable, Balance Labs makes no representations or warranties, expressed or implied, as to the accuracy or completeness of such information. In furnishing this information, Balance Labs reserves the right to amend or replace some or all of the information herein at any time and undertakes no obligation to provide the recipient with access to any additional information. Nothing contained herein is or should be relied upon as a promise or representation as to the future.

Forward-looking Statements: Certain matters discussed in this announcement contain statements, estimates and projections that involve risks to and uncertainties in Balance Labs' business that may cause actual results to differ materially from those anticipated by the statements made herein. Such statements, estimates and projections constitute forward-looking statements within the meaning of the federal securities laws. Balance Labs undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. The recipient of this information is cautioned not to place undue reliance on forward-looking statements. No representations or warranties are made as to the accuracy of such forward-looking statements or whether any of the projections included herein will be realized.

Balance Labs, Inc.
Carmen Villegas
+1(305) 907-7600

Source: Balance Labs, Inc.